R.28 EPC Exceptions to patentability

Under Article 53(a), European patents shall not be granted in respect of biotechnological inventions which, in particular, concern the following:
processes for cloning human beings; 
processes for modifying the germ line genetic identity of human beings; 
uses of human embryos for industrial or commercial purposes; 
processes for modifying the genetic identity of animals which are likely to cause them suffering without any substantial medical benefit to man or animal, and also animals resulting from such processes. 
Under Article 53(b), European patents shall not be granted in respect of plants or animals exclusively obtained by means of an essentially biological process.
Amended by decision of the Administrative Council CA/D 6/17 of 29.06.2017 (OJ EPO 2017, A56), which entered into force on 01.07.2017.
See decision of the Enlarged Board of Appeal G 2/06 (Annex I).
See opinion of the Enlarged Board of Appeal G 3/19 (Annex I).

50 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPC Implementing Rules

EPO Guidelines - F The European Patent Application

EPO Guidelines - G Patentability

Offical Journal of the EPO

Case Law Book: I Patentability

Case Law Book: II Conditions to be met by an Application

Case Law Book: III Amendments

Case Law Book: V Priority

Case Law Book: VII Proceedings before the EPO

Case Law of the Enlarged Board

General Case Law